Amphastar Pharmaceuticals’ first quarter was marked by flat revenue and a significant shortfall in non-GAAP profit compared ...

We recently compiled a list of the 8 Best Small Cap Pharma Stocks to Buy Right Now. Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is among the best pharmaceutical stocks on this list. TheFly reported ...

We recently compiled a list of the 8 Best Small Cap Pharma Stocks to Buy Right Now. Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is among the best pharmaceutical stocks on this list. TheFly reported ...

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is among the best pharmaceutical stocks on this list. TheFly reported on May 13 that Wells Fargo downgraded AMPH to Equal Weight from Overweight, with the ...

Net Revenue -- $171.2 million, rising slightly from $170.5 million in the prior-year period and supported by new product ...

Net revenues of $171.2 million for the three months ended March 31, 2026GAAP net income of $6.4 million, or $0.14 per share, for the first quarterAdjusted non-GAAP net income of $19.5 million, or $0.4 ...

Revenue from Vaxini was pressured by lower average selling prices linked to higher rebates and 340B discounts; these pricing headwinds are expected to persist in the near term according to management ...

The National Pharmaceutical Pricing Authority (NPPA) has revised the retail price of 42 new drugs, which include ...

Q1 2026 Management view Dan Dischner (Senior Vice President of Human Resources & Corporate Communication) said Q1 reflected “a return to growth, driven primarily by contributions from recent product ...

The National Pharmaceutical Pricing Authority (NPPA) has notified retail price of 42 new drugs under the provisions of the Drugs Prices Control Order (DPCO), 2013, including anti hypertensive, anti ...